Ovid Therapeutics Inc reports results for the quarter - Earnings Summary

Ovid Therapeutics

12/11/2024 15:33

* Ovid Therapeutics Inc  OVID.OQ  reported a quarterly
adjusted
loss of 20 cents​​ per share for the quarter , lower than the
same quarter last year, when the company reported EPS of -16
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 20 cents per share. Wall Street expected
results to range from -29 cents to -15 cents per share.
    * Revenue rose 58.8% to $173.00 thousand from a year ago;
analysts
expected $87.14 thousand. 
    * Ovid Therapeutics Inc's reported EPS for the quarter was a
loss
of 20 cents​.
    * The company reported a quarterly loss of $14.01 million.
    * Ovid Therapeutics Inc shares had risen by 15.3% this
quarter and
lost 57.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ovid Therapeutics
Inc is $3.00 
This summary was machine generated from LSEG data November 12 at
03:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.20          -0.20          Met
 Jun. 30 2024      -0.22          0.12           Beat
 Mar. 31 2024      -0.22          -0.17          Beat
 Dec. 31 2023      -0.05          -0.22          Missed